Regeneron Pharma Q2 Results Top Estimates - Update

RTTNews | 790 hari yang lalu
Regeneron Pharma Q2 Results Top Estimates - Update

(RTTNews) - Biotechnology company Regeneron Pharmaceuticals, Inc. (REGN) reported on Thursday that net income for the second quarter increased to $1.43 billion or $12.41 per share from $968 million or $8.50 per share in the prior-year quarter.

Excluding items, adjusted earnings for the quarter $1.35 billion or $11.56 per share, compared to $1.18 billion or $10.24 per share in the year-ago quarter.

On average, 23 analysts polled by Thomson Reuters expected the company to report earnings of $10.61 per share for the quarter. Analysts' estimates typically exclude special items.

Total revenue for the quarter grew 12 percent to $3.55 billion from $3.16 billion in the same quarter last year. Analysts were looking for revenues of $3.38 billion for the quarter.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

baca selengkapnya
Regeneron Says CHMP Recommends Conditional Marketing Authorization For Odronextamab In EU

Regeneron Says CHMP Recommends Conditional Marketing Authorization For Odronextamab In EU

Regeneron Pharmaceuticals, Inc. (REGN) announced Friday that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending conditional marketing authorization of odronextamab to treat adults with relapsed/refractory (R/R) follicular lymphoma (FL) or R/R diffuse large B-cell lymphoma (DLBCL), after two or more lines of systemic therapy.
RTTNews | 824 hari yang lalu
Regeneron Pharma Q4 Results Top Estimates - Update

Regeneron Pharma Q4 Results Top Estimates - Update

Regeneron Pharmaceuticals, Inc. (REGN) reported on Friday that net income for the fourth quarter declined 3 percent to $1.16 billion or $10.19 per share from $1.20 billion or $10.50 per share in the prior-year quarter.
RTTNews | 971 hari yang lalu
Regeneron Completes Acquiring Sanofi's Stake In Libtayo

Regeneron Completes Acquiring Sanofi's Stake In Libtayo

Regeneron Pharmaceuticals, Inc. (REGN) announced Friday that it has completed the acquisition of French drug major Sanofi's (SNYNF, SNY) stake in Libtayo (cemiplimab), providing Regeneron with exclusive worldwide development, commercialization, and manufacturing rights to the medicine originally discovered in Regeneron's laboratories. The intent to purchase Libtayo was announced on June 2, 2022.
RTTNews | 1552 hari yang lalu
Swiss Market Ends On Weak Note

Swiss Market Ends On Weak Note

The Switzerland stock market pared early gains and closed on a negative note on Wednesday as weak investor sentiment data and higher oil prices weighed.
RTTNews | 28 menit yang lalu
European Markets Close Weak On Higher Oil Prices, U.S.-Iran Deal Uncertainty

European Markets Close Weak On Higher Oil Prices, U.S.-Iran Deal Uncertainty

European stocks fell on Wednesday, hurt by higher bond yields and rising oil prices amid lingering uncertainty about Iran and the U.S. reaching a deal to end their conflict and pave the way for the reopening of the Strait of Hormuz. Some weak economic data from the region - UK GDP report being an exception - weighed as well on sentiment.
RTTNews | 56 menit yang lalu
Chicago Business Barometer Surges Back Into Expansionary Territory In September

Chicago Business Barometer Surges Back Into Expansionary Territory In September

A report released by MNI Indicators on Wednesday showed a substantial rebound by its reading on Chicago-area business activity in the month of September. MNI Indicators said its Chicago business barometer spiked to 58.8 in September from 47.1 in August, with a reading above 50 indicating growth. Economists had expected the index to jump to 51.0.
RTTNews | 4 jam 22 menit yang lalu
U.S. Consumer Prices Rise 0.3% In August, Slightly Less Than Expected

U.S. Consumer Prices Rise 0.3% In August, Slightly Less Than Expected

The Commerce Department released a closely watched report on Wednesday showing consumer prices in the U.S. rose by slightly less than expected in the month of August. The Commerce Department said its personal consumption expenditures (PCE) price index increased by 0.3 percent in August following a revised 0.1 percent uptick in July.
RTTNews | 4 jam 38 menit yang lalu